Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Acceleron Pharma Inc.

News headline image
Acceleron Reports Third Quarter 2021 Financial Results
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Announces Third Quarter 2021 REBLOZYL® Net Sales
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Reports Second Quarter 2021 Financial Results
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Announces Second Quarter 2021 REBLOZYL® Net Sales
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron to Webcast Second Quarter 2021 Financial Results on August 5, 2021
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron to Host Virtual Research and Development (R&D) Day on June 22, 2021
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Presents Preliminary Data from the SPECTRA Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) at the American Thoracic Society 2021 International Conference
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Presents Interim Results from the Open-label Extension of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension (PAH) at the American Thoracic Society 2021 International Conference
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2021 European Hematology Association Virtual Congress
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron to Host Conference Call and Webcast to Review Clinical Trial Updates, Preclinical Presentations on Sotatercept in Pulmonary Arterial Hypertension (PAH) Presented at the American Thoracic Society (ATS) 2021 International Conference
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Reports First Quarter 2021 Financial Results
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron Announces First Quarter 2021 REBLOZYL® Net Sales
From Acceleron Pharma Inc.
Via Business Wire
News headline image
Acceleron to Webcast First Quarter 2021 Financial Results on May 6, 2021
From Acceleron Pharma Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.